787 related articles for article (PubMed ID: 32126303)
21. Role of Gut Microbiota in Type 2 Diabetes Mellitus and Its Complications: Novel Insights and Potential Intervention Strategies.
Woldeamlak B; Yirdaw K; Biadgo B
Korean J Gastroenterol; 2019 Dec; 74(6):314-320. PubMed ID: 31870137
[TBL] [Abstract][Full Text] [Related]
22. Role of Microbiome and Antibiotics in Autoimmune Diseases.
Vangoitsenhoven R; Cresci GAM
Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
[TBL] [Abstract][Full Text] [Related]
23. [The gut microbiota, a new cardiovascular risk factor?].
Chong-Nguyen C; Duboc H; Sokol H
Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
[TBL] [Abstract][Full Text] [Related]
24. Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus.
Salgaço MK; Oliveira LGS; Costa GN; Bianchi F; Sivieri K
Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9229-9238. PubMed ID: 31664483
[TBL] [Abstract][Full Text] [Related]
25. Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes.
Sharma BR; Jaiswal S; Ravindra PV
Biomed Pharmacother; 2022 Aug; 152():113148. PubMed ID: 35665671
[TBL] [Abstract][Full Text] [Related]
26. Gut-targeted therapies for type 2 diabetes mellitus: A review.
Xu TC; Liu Y; Yu Z; Xu B
World J Clin Cases; 2024 Jan; 12(1):1-8. PubMed ID: 38292634
[TBL] [Abstract][Full Text] [Related]
27. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
Han JL; Lin HL
World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
[TBL] [Abstract][Full Text] [Related]
28. Diabetes and the Gut Microbiome.
Lau WL; Tran T; Rhee CM; Kalantar-Zadeh K; Vaziri ND
Semin Nephrol; 2021 Mar; 41(2):104-113. PubMed ID: 34140089
[TBL] [Abstract][Full Text] [Related]
29. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders.
Yoo JY; Kim SS
Nutrients; 2016 Mar; 8(3):173. PubMed ID: 26999199
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
Fong W; Li Q; Yu J
Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota and type 2 diabetes mellitus.
Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
33. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
Oka A; Sartor RB
Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
[TBL] [Abstract][Full Text] [Related]
34. Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential.
Hasain Z; Mokhtar NM; Kamaruddin NA; Mohamed Ismail NA; Razalli NH; Gnanou JV; Raja Ali RA
Front Cell Infect Microbiol; 2020; 10():188. PubMed ID: 32500037
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota and probiotics: Focus on diabetes mellitus.
Bordalo Tonucci L; Dos Santos KM; De Luces Fortes Ferreira CL; Ribeiro SM; De Oliveira LL; Martino HS
Crit Rev Food Sci Nutr; 2017 Jul; 57(11):2296-2309. PubMed ID: 26499995
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
Lee M; Chang EB
Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
[TBL] [Abstract][Full Text] [Related]
38. Human microbiome restoration and safety.
Daliri EB; Tango CN; Lee BH; Oh DH
Int J Med Microbiol; 2018 Jul; 308(5):487-497. PubMed ID: 29773467
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiome approaches to treat obesity in humans.
Bianchi F; Duque ALRF; Saad SMI; Sivieri K
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1081-1094. PubMed ID: 30554391
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
Caesar R
Can J Diabetes; 2019 Apr; 43(3):224-231. PubMed ID: 30929665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
